Malene Krogh
Aalborg, DK, 9000, Denmark
NCT Number: NCT05276778
Diabetic Retinopathy is a microvascular eye complication of diabetes, which can go unnoticed until permanent vision damage has occurred - in worst-case blindness. Timely retinopathy screenings reduce the risk of sight loss since the disease can be treated if detected in time. For people with type 2 diabetes, retinopathy screenings are typically performed by specialist at private ophthalmologists' practices, and individualized screening intervals based on retinopathy level and diabetes regulation are recommended. Unfortunately, 26% of people with type 2 diabetes do not follow their screening interval, and the attendance is too low compared to the national standard of minimum 90% of patients with diabetes who ought to follow the screening program. Consequently, actions must be taken to improve screening attendance in Denmark.
The aim of this study is to investigate patients' acceptance of diabetic retinopathy screenings in general practice. Patients' acceptance is explored through a questionnaire developed for the study.
Looking for future studies?
Notify Me18 year–70 year
All sexes
Observational
Aalborg, DK, 9000, Denmark
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Screenings are performed in the diabetes consultation in general practice
Time frame: 1 day (the questionnarie is fufilled one time after the retinopaty screening in general practice)
Questionnaire
Aalborg University
Other
Diabetic Retinopathy Screenings in General Practice for People With Type 2 Diabetes
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02662010
Cardiovascular Diseases, Diabetes Complications
Aurora, Colorado, United States
View Trial DetailsNCT00542178
Cardiovascular Diseases, Diabetes Complications
Minneapolis, Minnesota, United States
View Trial DetailsNCT02625649
Body Weight, Cardiovascular Diseases
Aarhus, Denmark
View Trial DetailsNCT01179555
Cardiovascular Diseases, Diabetes Complications
Philadelphia, Pennsylvania, United States
View Trial Details